Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | TDO2 | P48775 | 1/20 | 0.44 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.42 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.40 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HCAR1 | Q9BXC0 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27379060 | 0.89 | NPEPPS (0.41) | IDO1TDO2NPEPPSKDM4EHTT | |
| SCHEMBL29326614 | 0.85 | KDM4E (0.45) | IDO1TDO2NPEPPSITGA4ITGB7 | |
| SCHEMBL29326618 | 0.84 | HCAR1 (0.40) | NPEPPSITGA4ITGB7TDP1KDM4E | |
| SCHEMBL29326223 | 0.81 | FEN1 (0.58) | NPEPPSTDP1KDM4EHTTGAA | |
| SCHEMBL29326228 | 0.79 | PLK4 (0.41) | NPEPPSITGA4ITGB7TDP1KDM4E | |
| SCHEMBL29326229 | 0.77 | FEN1 (0.61) | NPEPPSITGA4ITGB7TDP1KDM4E | |
| SCHEMBL29326253 | 0.77 | NPEPPS (0.42) | NPEPPSITGA4ITGB7TDP1KDM4E | |
| SCHEMBL6976268 | 0.77 | NPEPPS (0.63) | NPEPPSTDP1KDM4EHTTGAA | |
| SCHEMBL29326265 | 0.76 | PTGES (0.46) | NPEPPSTDP1KDM4EHTTALDH1A1 | |
| SCHEMBL27192007 | 0.76 | KDM4E (0.42) | NPEPPSKDM4EHTTGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | ACE2, TMPRSS2, ACE | IDO1 1204/4885TDO2 1333/4885NPEPPS 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.